Ndị na-emepụta ngwaahịa & ndị na-ebubata ngwaahịa - Ụlọ ọrụ ngwaahịa China

Lasofoxifene Tartrate CAS 190791-29-8 Chiral Dị Ọcha ≥99.0% Ịdị Ọcha ≥98.0% (HPLC) API Ịdị Ọcha Dị Elu

Aha Chemical: Lasofoxifene Tartrate

OZI: 190791-29-8

Ọdịdị: White ka Gbanyụọ-Ọcha ntụ ntụ

Ịdị ọcha nke Chiral: ≥99.0%Ịdị ọcha: ≥98.0% (HPLC)

Na ọgwụgwọ nke Postmenopausal Osteoporosis

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality

Aha kemịkal: Imatinib Mesylate (ụdị alpha)

Ọnọdụ: 220127-57-1

Ọdịdị: White ka Gbanyụọ-White Crystalline ntụ ntụ

Nyocha HPLC: 98.0% ~ 102.0%

Imatinib Mesylate na ọgwụgwọ nke Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+CML)

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Intermediate High Purity

Aha: N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea

Synonyms: Imatinib Mesylate Intermediate

Ọnọdụ: 152460-10-1

Ọdịdị: Orange Light Ka Yellow Powder ruo Crystal

Ịdị ọcha: ≥98.0% (HPLC)

Otiti nke Imatinib Mesylate (CAS: 220127-57-1) na ọgwụgwọ nke Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Purity

4-[(4-Methylpiperazin-1-yl)methyl] benzoic Acid Dihydrochloride

Nọmba: 106261-49-8

Ọdịdị: Ọcha ka ọ fọrọ nke nta ka ọ bụrụ ọcha ntụ ntụ na kristal

Ịdị ọcha: ≥98.0% (HPLC)

Otiti nke Imatinib Mesylate (CAS: 220127-57-1) na ọgwụgwọ nke Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
N- (2-Methyl-5-nitrophenyl) -4- (pyridin-3-yl) pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Intermediate High Purity

N- (2-Methyl-5-nitrophenyl) -4- (pyridin-3-yl) pyrimidin-2-amine

Nọmba: 152460-09-8

Ọdịdị: Yellow ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ntụ ntụ

Ịdị ọcha: ≥98.0% (HPLC)

Otiti nke Imatinib Mesylate (CAS: 220127-57-1) na ọgwụgwọ nke Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Ịdị ọcha ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Aha ọgwụ: 3,6-Dichloropyrazine-2-Carbonitrile

Nọmba: 356783-16-9

Ọdịdị: Yellow na-acha odo odo ruo na-acha ọcha ntụ ntụ

Dị ọcha: ≥99.0% (HPLC)

Ndị etiti nke Favipiravir (CAS: 259793-96-9) na ọgwụgwọ ndị ọrịa nwere COVID-19 nke WHO kwadoro.

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Ịdị ọcha ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Aha ọgwụ: 3,6-Difluoropyrazine-2-Carbonitrile

Nọmba: 356783-28-3

Ọdịdị: Yellow na-acha odo odo ruo na-acha ọcha ntụ ntụ

Dị ọcha: ≥99.0% (HPLC)

Otiti nke Favipiravir (CAS 259793-96-9) na ọgwụgwọ nke Influenza Virus Infection na COVID-19

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6 Dị Ọcha ≥99.0% Favipiravir Intermediate COVID-19

Aha kemịkal: Diethyl Aminomalonate Hydrochloride

Ọkụ: 13433-00-6

Ọdịdị: White ma ọ bụ Gbanyụọ-White Crystalline ntụ ntụ

ịdị ọcha: ≥99.0%

Ndị etiti nke Favipiravir (CAS: 259793-96-9) na ọgwụgwọ ndị ọrịa nwere COVID-19 nke WHO kwadoro.

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
2-Aminopropanediamide CAS 62009-47-6 Favipiravir Intermediate COVID-19 Dị Ọcha Dị Elu

Aha ọgwụ: 2-Aminopropanediamide

Ọkụ: 62009-47-6

Ọdịdị: Light Yellow Powder

Ọdịmma: ≥98.0% (LCMS-ELSD)

Ndị etiti nke Favipiravir (CAS: 259793-96-9) na ọgwụgwọ ndị ọrịa nwere COVID-19 nke WHO kwadoro.

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
Favipiravir CAS 259793-96-9 T-705 Dị Ọcha ≥99.0% (HPLC) COVID-19 API Ụlọ ọrụ dị elu

Aha ọgwụ: Favipiravir;T-705

CAS: 259793-96-9

Ọdịdị: White ka Gbanyụọ-Ọcha ntụ ntụ

Dị ọcha: ≥99.0% (HPLC)

Na ọgwụgwọ nke Influenza Virus Infection na COVID-19

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
Cetrorelix Acetate CAS 130143-01-0 GnRH Onye na-emegide Peptide Purity (HPLC) ≥98.0% Ogo dị elu

Aha Chemical: Cetrorelix Acetate

Ọnọdụ: 130143-01-0

Ọdịdị: White ntụ ntụ

Peptide dị ọcha (HPLC): ≥98.0%

Synthetic antagonist nke GnRH Nnabata

GMP Peptides, API, Ogo dị elu

Kpọtụrụ: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

ajuju nkọwa
Deslorelin Acetate CAS 57773-65-6 GnRH Agonist High Quality Peptide Purity (HPLC) ≥98.0%

Aha Chemical: Deslorelin Acetate

CAS: 57773-65-6

Ọdịdị: White Powder ma ọ bụ fọrọ nke nta ka ọ dị ọcha ntụ ntụ

Peptide dị ọcha (HPLC): ≥98.0% (Site na Njikọ Mpaghara)

Ọdịnaya Peptide (N%): ≥80.0%

Nyocha: 95.0% ~ 105.0% (Site na Anhydrous, Acetic Acid na-enweghị)

GnRH Agonist

Inquiry: alvin@ruifuchem.com

ajuju nkọwa
Octreotide Acetate CAS 83150-76-9 Peptide Purity (HPLC) ≥98.0% API Ogo dị elu

Aha Chemical: Octreotide Acetate

CAS: 83150-76-9

Ọdịdị: White ntụ ntụ

Peptide dị ọcha (site na HPLC): ≥98.0%

Nyocha: 95% ~ 105%

Acromegaly na Gastroenteropancreatic Tumor

Kpọtụrụ: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

ajuju nkọwa
Sodium Valproate (VPA) CAS 1069-66-5 API Ụlọ ọrụ dị ọcha dị elu

Aha kemịkal: Sodium Valproate (VPA)

Ihe atụ: Valproic Acid Sodium nnu

Ọkụ: 1069-66-5

Ọdịdị: White ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ White Crystalline ntụ ntụ, Hygroscopic

Nyocha: 98.5% ~ 101.0% (Titration)

A na-anabatakarị ọgwụ mgbochi Akwụkwụ na-adọ nke Broad-Spectrum

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

ajuju nkọwa

<< < gara aga 324 325 326 327 328 329 330 Ọzọ >>> Peeji 327 / 341

Ngwaahịa

Tetrabutylammonium Fluoride Trihydrate CAS 87749-50-6 Dị Ọcha>99.0% (Titration)

Tetrabutylammonium Bromide (TBAB) CAS 1643-19-2 Ịdị ọcha> 99.0% ((Titration)

Ammonium Bromide CAS 12124-97-9 Ịdị ọcha>99.0% (Titration)

Tetra-n-Octylammonium Bromide (TOAB) CAS 14866-33-2 Dị Ọcha> 98.0% (Titration)

Didodecyldimethylammonium Bromide CAS 3282-73-3 Dị Ọcha> 99.0% (GC)

(S)-(-)-TolBINAP CAS 100165-88-6 Ịdị ọcha>98.0% (HPLC)

Dibromobis (triphenylphosphine) nickel (II) CAS 14126-37-5 Ịdị ọcha> 99.0% (GC)

tert-Amyl Alcohol CAS 75-85-4 Ịdị Ọcha>99.5% (GC)

tert-Butyl Hydroperoxide (TBHP) (70% na mmiri) CAS 75-91-2

Sodium tert-Butoxide CAS 865-48-5 Ịdị ọcha>99.0% (T)

Lithium tert-Butoxide CAS 1907-33-1 Ịdị ọcha>99.0% (Titration)

Trimethyltetradecylammonium Chloride CAS 4574-04-3 Dị Ọcha> 99.0% (T)

Tributyltin Hydride CAS 688-73-3 Dị Ọcha>97.0% (GC) nwere 0.05% BHT dị ka Stabilizer

Lasofoxifene Tartrate CAS 190791-29-8 Chiral Dị Ọcha ≥99.0% Ịdị Ọcha ≥98.0% (HPLC) API Ịdị Ọcha Dị Elu

Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality

N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Intermediate High Purity

4-[(4-Methylpiperazin-1-yl) methyl] benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Purity

N- (2-Methyl-5-nitrophenyl) -4- (pyridin-3-yl) pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Intermediate High Purity

3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Ịdị ọcha ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Ịdị ọcha ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Diethyl Aminomalonate Hydrochloride CAS 13433-00-6 Dị Ọcha ≥99.0% Favipiravir Intermediate COVID-19

2-Aminopropanediamide CAS 62009-47-6 Favipiravir Intermediate COVID-19 Dị Ọcha Dị Elu

Favipiravir CAS 259793-96-9 T-705 Dị Ọcha ≥99.0% (HPLC) COVID-19 API Ụlọ ọrụ dị elu

Cetrorelix Acetate CAS 130143-01-0 GnRH Onye na-emegide Peptide Purity (HPLC) ≥98.0% Ogo dị elu

Deslorelin Acetate CAS 57773-65-6 GnRH Agonist High Quality Peptide Purity (HPLC) ≥98.0%

Octreotide Acetate CAS 83150-76-9 Peptide Purity (HPLC) ≥98.0% API Ogo dị elu

Sodium Valproate (VPA) CAS 1069-66-5 API Ụlọ ọrụ dị ọcha dị elu